TB medication variations in private markets could harm treatment efforts, study says

A wide variation in the dosages and forms of medicines prescribed by private physicians to patients with in developing countries could lead to the development of more -resistant strains of the bacterial infection, according to a study published Wednesday in PLoS One, the Financial Times reports.


Read more

Related posts

Leave a Reply